Timothy C. Mills

Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California.

Tenex Greenhouse Ventures LLC is an Independent Venture Capital firm founded in 2001. Tenex Greenhouse Ventures LLC is headquartered in Burlingame.

Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA.

Dynatherm Medical, Inc. developed mammalian temperature regulation products. It offered products for temperature management in surgical, emergency, field and industrial settings. The company was founded in 2003 and was headquartered in Fremont, CA.

Theregen, Inc. develops cell based therapies for cardiovascular and vascular disorders. Its product Anginera is a cell-based, three-dimensional human tissue patch that induces formation of mature blood vessels in the human myocardium. The company was founded by Michael Siani-Rose and H. Martin Lades in 2003 and is headquartered in San Francisco, CA.

Torax Medical Inc. designs and develops medical devices to treat chronic diseases related to defective sphincter muscles. Its technology platform, Magnetic Sphincter Augmentation (MSA), uses attraction forces to augment weak or defective sphincter muscles to treat gastroesophageal reflux disease (GERD) and fecal incontinence (FI). The firm's products include LINX, a reflux management system for the treatment of GERD; and FENIX, a continence restoration system for the treatment of FI. The company was founded by Todd Berg in 2002 and is headquartered in Shoreview, MN.

Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway. Based on new insights and unique proprietary technology related to complement biology, Taligen is building a deep product candidate pipeline of novel protein therapeutics which selectively identify, target and concentrate on inflammatory tissues. Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts.

Naviscan, Inc. develops, manufactures, and markets organ molecular imaging scanners. The company was founded by Irving Weinberg on January 31, 2006 and is headquartered in San Diego, CA.

NovoStent Corp. develops and manufactures helical stent and delivery systems. It also develops and manufactures implantable medical devices. The company was founded by Michael Hogendijk and is headquartered in Mountain View, CA.